Clinical Research Directory
Browse clinical research sites, groups, and studies.
18F-FDG PET/TC in TIR3A e TIR3B
Sponsor: IRCCS Azienda Ospedaliero-Universitaria di Bologna
Summary
The primary objective of this study is to evaluate the diagnostic performance of 18F-FDG PET/CT performed by normal care pathway in the identification of malignancy of undetermined resulting thyroid lesions at cytology (TIR3A and TIR3B) comparing the 18F-FDG PET/CT result with histological data. The secondary objective is to identify possible PET/ultrasound/genetic/radiomics variables that can more accurately define the potential malignancy of undetermined nodules and create a predictive model of malignity fed by standard parameters (derived from the normal care path). The identification of the prognostic value of 18F-FDG PET/CT in such patients setting could, in fact, make the PET useful in the future in the selection of patients for surgery/ follow-up.
Official title: Utilizzo Della 18F-FDG PET/TC Per Stratificare il Rischio di malignità Dei Noduli Tiroidei a Citologia Indeterminata (TIR3A e TIR3B)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
216
Start Date
2022-03-22
Completion Date
2027-02-01
Last Updated
2025-02-17
Healthy Volunteers
No
Interventions
clinical practice drug treatment
The study is observational, non-interventional and involves the review of the investigation18F-FDGPET/TC (performed according to the EANM guidelines) by two experts from the Nuclear Medicine Department.
Locations (1)
Nuclear medicine, IRCCS, Azienda Ospedalierio-Universitaria di Bologna
Bologna, Italy, Italy